Clinical Trials

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women (CTMS# 17-0014)

Cancer Type

Ovary

ClinicalTrials.gov Identifier

NCT00539162

Principal Investigator

Georgia McCann MD

For more information about this study
View Details

About This Study

The goal of this clinical research study is to evaluate a method involving a blood test, called CA-125, that may be helpful in the early detection of ovarian cancer in women who are at low risk.